Resistance to Pembrolizumab and Axitinib in Renal Cell Carcinoma: Clinical and Genomic Evaluation. jkcvhl [Internet]. 2020 Jun. 2 [cited 2026 Apr. 27];7(1):7-11. Available from: https://mail.jkcvhl.com/index.php/jkcvhl/article/view/135